Role of the Class IA PI3K in Hematopoietic Stem Cell Self-Renewal

Information

  • Research Project
  • 10479621
  • ApplicationId
    10479621
  • Core Project Number
    F32HL146119
  • Full Project Number
    3F32HL146119-02S1
  • Serial Number
    146119
  • FOA Number
    PA-18-670
  • Sub Project Id
  • Project Start Date
    1/1/2020 - 4 years ago
  • Project End Date
    12/31/2022 - a year ago
  • Program Officer Name
    OCHOCINSKA, MARGARET J
  • Budget Start Date
    9/10/2021 - 2 years ago
  • Budget End Date
    12/31/2021 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
    S1
  • Award Notice Date
    9/9/2021 - 2 years ago

Role of the Class IA PI3K in Hematopoietic Stem Cell Self-Renewal

Proposal Summary/Abstract Adult hematopoietic stem cells (HSCs) are a rare and unique population of stem cells that reside in the bone marrow, where they undergo self-renewal and differentiation to maintain the blood system. To properly maintain the balance between self-renewal and differentiation, HSCs receive signals from growth factors and chemokines to activate the evolutionarily conserved phosphoinositide 3-kinase/Protein Kinase B (PI3K/AKT) signaling pathway. Pathologic activation of this pathway is frequently observed in cancers, including leukemia, making it a desirable target for cancer treatment. Several PI3K inhibitors are already used in the clinic and to better inform therapeutic targeting, it is crucial to understand the roles of PI3K in adult HSCs. Hematopoietic cells express three Class IA catalytic isoforms of PI3K (p110?, ?, ?), all of which can transduce growth factor and cytokines signals. Out of these isoforms, p110? is unique, since in addition to transducing growth factor signals through receptor tyrosine kinases (RTK), it can directly interact with G-protein coupled receptor G?? subunits to transduce chemokines, and also binds to RAC and to RAB5 GTPases. In mouse embryonic fibroblasts, the p110?-RAB5 interaction was shown to be important for the induction of autophagic cellular recycling process, which is essential for the maintenance of HSC metabolism and self- renewal. Individual Class 1A PI3K isoforms have unique functions in mature hematopoietic lineages, but they are dispensable for HSCs function. To study the redundant roles of Class 1A PI3K in HSCs, we have generated a triple knockout (TKO) mouse model with conditional deletion of p110? and p110? in hematopoietic cells, and germline deletion of p110?. Analysis of these TKO mice reveals upon the loss of all three Class1A isoforms causes an increase in HSCs numbers, but decreased self-renewal and differentiation, with inefficient repopulation of all mature blood lineages. This phenotype is different from the phenotypes of any PI3K single isoform knockout mouse model, and even from p110?;? double knockout animals, suggesting that p110? isoform plays an important compensatory role in HSCs. Moreover, my data suggests that loss of Class I PI3K causes a decrease in autophagy induction upon growth factor deprivation, though autophagy can still be induced with the mTOR inhibitor rapamycin. Thus, I hypothesize that loss of Class IA PI3K compromises autophagy induction, which causes altered HSC metabolism and impaired HSCs fitness. The proposed studies will use our PI3K TKO mouse model to elucidate in Aim 1 the cellular mechanism for defective self-renewal in HSCs. Aim 2 will establish the roles of autophagy in TKO HSC dysfunction. Lastly, Aim 3 will determine which binding interactions of p110? are the most important for its compensatory role in HSC function. In summary, this research will delineate the cellular and molecular mechanisms by which Class 1A PI3K supports HSC self-renewal and differentiation.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    F32
  • Administering IC
    HL
  • Application Type
    3
  • Direct Cost Amount
    2500
  • Indirect Cost Amount
  • Total Cost
    2500
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    839
  • Ed Inst. Type
  • Funding ICs
    NHLBI:2500\
  • Funding Mechanism
    TRAINING, INDIVIDUAL
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ALBERT EINSTEIN COLLEGE OF MEDICINE
  • Organization Department
  • Organization DUNS
    081266487
  • Organization City
    BRONX
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    104611900
  • Organization District
    UNITED STATES